Maayan Shiner

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

Pomegranate Phenolics from the Peels, Arils, and Flowers Are Antiatherogenic: Studiesin Vivoin Atherosclerotic Apolipoprotein E-Deficient (E⁰) Mice andin Vitroin Cultured Macrophages and Lipoproteins

Pomegranate and its Many Functional Components as Related to Human Health: A Review

Bioactives from fruit processing wastes: Green approaches to valuable chemicals

Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: Studies in vitro and in diabetic patients

The Effect of Pomegranate (Punica granatumL.) Byproducts and Ellagitannins on the Growth of Human Gut Bacteria

The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology

Nitric oxide and oxidative stress in vascular disease

The strawberry: Composition, nutritional quality, and impact on human health

Ellagitannins, ellagic acid and vascular health

NADPH Oxidase-Derived Reactive Oxygen Species Mediate the Cerebrovascular Dysfunction Induced by the Amyloid β Peptide

The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases

Paraoxonase 1 (PON1) inhibits monocyte-to-macrophage differentiation

Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice

<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>

Endothelial dysfunction — A major mediator of diabetic vascular disease

The Pathobiology of Vascular Dementia

Pomegranate peel and peel extracts: Chemistry and food features

Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases

Therapeutic applications of pomegranate (Punica granatum L.): a review.

Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health

CYP2C19 But Not PON1 Genetic Variants Influence Clopidogrel Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy in Post–Myocardial Infarction Patients

Pathophysiology of Type 2 Diabetes Mellitus

The Reciprocal Interactions between Polyphenols and Gut Microbiota and Effects on Bioaccessibility

Reactive Oxygen Species in Metabolic and Inflammatory Signaling

Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So Far

Pomegranate as a Functional Food and Nutraceutical Source

Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages

Cell-induced copper ion-mediated low density lipoprotein oxidation increases during in vivo monocyte-to-macrophage differentiation

Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPARγ and AP-1 pathway activation

Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties

Macrophage paraoxonase 2 (PON2) expression is upregulated by unesterified cholesterol through activation of the phosphatidylinositol 3-kinase (PI₃K) pathway